European bronchitis treatment market is projected to witness considerable growth during the forecast period. Significant rise in the prevalence of asthma is the major factor contributing to the demand for bronchitis treatment in the country. Considerable increasing healthcare spending and rise in ageing population are some crucial factors significantly increased the demand for bronchitis treatment in the region. Moreover, it has been estimated by Health and Safety Executive that about 15% of the total respiratory diseases are diagnosed in the people working at dusty workplace.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/europe-bronchitis-treatment-market

Regarding this, the Government of UK had launched surveillance of work-related and occupational respiratory disease (SWORD) scheme. About 420 physicians report regarding the workplace respiratory diseases among the employees. This is offering growth to the bronchitis treatment market in European region.

A Full Report ofEuropean Bronchitis Treatment Market is Available at:https://www.omrglobal.com/industry-reports/europe-bronchitis-treatment-market

European bronchitis treatment market is classified on the basis of type of treatment, which includes drugs and oxygen therapy. The drugs segment is further segregated into antibiotics, anti-inflammatory drugs, bronchodilators, and others. Among these types of treatments, the drugs find its significant application in the bronchitis treatment across the globe. In addition, the bronchodilator is estimated to project a considerable CAGR during the forecast period. Bronchodilators are the first-line medication used to treatment of bronchitis, to clear the airway obstruction, which is considered as first-step in chronic bronchitis to ease breathing problems.

European Bronchitis Treatment Market-- Segmentation
European Bronchitis Treatment Market by Type
• Drugs
o Antibiotics
o Anti-inflammatory drugs
o Bronchodilators
o Others (Mucolytics)
• Oxygen Therapy

European Bronchitis Treatment Market – Segment by Region
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Company Profiles
• Abbott Laboratories
• Bayer AG
• Boehringer Ingelheim International GmbH
• Cipla Ltd.
• GlaxoSmithKline PLC
• Lupin Pharmaceuticals, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/europe-bronchitis-treatment-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404